[168]
Dr. Bucci, the Applicants' witness, testified that, in comparison to ofloxacin, levofloxacin's increased solubility had the double benefit of allowing the drug to be formulated at a higher concentration at the required neutral pH and of allowing it to better penetrate the corneal tissue. He further provided that levofloxacin's greater solubility and improved activity over ofloxacin is of great practical usefulness and significance for ophthalmic purposes, arising from levofloxacin's ability to better penetrate into ocular tissues and fluid. (Bucci Affidavit at paras. 37, 43, AR, v. 1, Tab 2, pp. 41, 43-44.)
(d) Levofloxacin's Combination of the Three Beneficial Properties was Unexpected